Olink Proteomics provides the most efficient tool available for targeted human protein biomarker discovery, development and implementation. Our disease or biology-focused immunoassay panels enable rapid, high-throughput analysis, with exceptional data quality and minimal sample consumption. Using just 1 µl of sample, 92 biomarkers are assayed simultaneously on each panel, with results in only 24 hours. Olink’s Proximity Extension Assay (PEA) technology enables this high level of multiplexing, as this dual recognition, DNA-coupled method provides exceptional readout specificity. The current library enables rapid analysis of more than 1,000 validated protein biomarkers with less than 15 µl of sample. Olink panels are available via our Analysis Service or as kits. With over half a million samples analyzed and a team of specialist data scientists, Olink also has the expertise to maximize the success of protein biomarker studies. The company is headquartered in Uppsala, and also has a major regional office and service lab in Boston MA, as well as a rapidly expanding global sales organization.